Latest Biotechnology Partnerships News

Page 1 of 1

Starpharma Raises $32 Million to Propel DEP® HER2-Lutetium Trial and Oncology Pipeline

Starpharma launches a fully underwritten $32 million entitlement offer to fund the Phase 1 trial of its DEP® HER2-Lutetium radiopharmaceutical and accelerate its targeted oncology asset development.

Ada Torres

15 July 2026

Rhythm Biosciences Locks in Multi-Year Manufacturing Deal for ColoSTAT® Kits

Rhythm Biosciences has secured a multi-year commercial manufacturing agreement with US-based Quansys Biosciences to produce ColoSTAT® reagent kits, paving the way for broader market rollout of its colorectal cancer diagnostic test.

Ada Torres

3 Feb 2026

Browse the archive

Full archive

Aug 2026 July 2026 June 2026 May 2026 Apr 2026 Mar 2026 Feb 2026 Jan 2026